Tandem Diabetes Care, Inc. (TNDM) Stock Price

TNDMStock

$16.24+6.21%52W

Market Cap$1.13B

P/E—

PEG Ratio—

Div yield—

Beta1.62

TNDM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-32.98%

Price vs S&P 500 (4W)-6.51%

VGM Score46.02

Book Value / Share (Quarterly)$1.88

P/TBV (Annual)10.39x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)8.19%

Cash Flow / Share (Quarterly)$-1.55

Price vs S&P 500 (YTD)-38.04%

Gross Margin (TTM)56.01%

Net Profit Margin (TTM)-6.08%

EPS (TTM)$-0.93

10-Day Avg Trading Volume2.16M

EPS Excl Extra (TTM)$-0.93

Revenue Growth (5Y)15.26%

EPS (Annual)$-3.04

ROI (Annual)-43.55%

Gross Margin (Annual)53.81%

Net Profit Margin (5Y Avg)-13.95%

Cash / Share (Quarterly)$6.56

Revenue Growth QoQ (YoY)5.77%

ROA (Last FY)-23.23%

Revenue Growth TTM (YoY)3.96%

EBITD / Share (TTM)$-0.41

ROE (5Y Avg)-51.46%

Operating Margin (TTM)-4.40%

Cash Flow / Share (Annual)$-0.43

P/B Ratio8.67x

P/B Ratio (Quarterly)7.93x

Net Income / Employee (Annual)$-81,900

EV / Revenue (TTM)1.61x

Net Interest Coverage (TTM)-14.39x

ROA (TTM)-6.23%

EV / EBITDA (TTM)239.23x

EPS Incl Extra (Annual)$-3.04

Current Ratio (Annual)2.55x

Quick Ratio (Quarterly)2.44x

3-Month Avg Trading Volume2.04M

52-Week Price Return6.21%

Revenue / Employee (TTM)$416,600

Tangible BV / Share (Quarterly)$2.10

P/S Ratio (Annual)1.11x

Asset Turnover (Annual)1.15x

52-Week High$29.65

Operating Margin (5Y Avg)-13.73%

EPS Excl Extra (Annual)$-3.04

CapEx CAGR (5Y)-9.19%

Tangible BV CAGR (5Y)-16.69%

26-Week Price Return-23.07%

Quick Ratio (Annual)1.89x

13-Week Price Return-4.92%

Total Debt / Equity (Annual)2.03x

Current Ratio (Quarterly)3.18x

Enterprise Value$1.67B

Revenue / Share Growth (5Y)13.02%

Asset Turnover (TTM)1.03x

Book Value / Share Growth (5Y)-17.32%

Revenue / Employee (Annual)$405,900

Inventory Turnover (Annual)3.37x

Pretax Margin (Annual)-19.74%

Cash / Share (Annual)$4.29

3-Month Return Std Dev63.06%

Gross Margin (5Y Avg)52.03%

Net Income / Employee (TTM)$-25,300

EBITDA Interim CAGR (5Y)-10.36%

ROE (Last FY)-131.93%

Net Interest Coverage (Annual)-3.01x

EPS Basic Excl Extra (Annual)$-3.04

P/FCF (TTM)93.68x

Receivables Turnover (TTM)7.17x

Total Debt / Equity (Quarterly)4.66x

EPS Incl Extra (TTM)$-0.93

Receivables Turnover (Annual)7.25x

ROI (TTM)-10.58%

P/S Ratio (TTM)1.08x

Pretax Margin (5Y Avg)-13.66%

Revenue / Share (Annual)$15.08

Tangible BV / Share (Annual)$2.10

Price vs S&P 500 (52W)-9.32%

Year-to-Date Return-26.11%

5-Day Price Return-1.28%

EPS Normalized (Annual)$-3.04

ROA (5Y Avg)-12.76%

Net Profit Margin (Annual)-20.17%

Month-to-Date Return-0.43%

Cash Flow / Share (TTM)$-2.98

EBITD / Share (Annual)$-2.52

Operating Margin (Annual)-18.45%

LT Debt / Equity (Annual)2.03x

P/CF (TTM)78.21x

ROI (5Y Avg)-21.38%

LT Debt / Equity (Quarterly)4.66x

EPS Basic Excl Extra (TTM)$-0.93

P/TBV (Quarterly)10.39x

P/B Ratio (Annual)9.60x

Inventory Turnover (TTM)3.30x

Pretax Margin (TTM)-5.86%

Book Value / Share (Annual)$2.27

Price vs S&P 500 (13W)-7.60%

Beta1.62x

P/FCF (Annual)150.66x

Revenue / Share (TTM)$15.09

ROE (TTM)-45.97%

52-Week Low$12.26

vGradeD

gGradeC

mGradeC

vgmGradeC

TNDM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.32	-$0.31	+2.75%(+$0.01)
Q1 2026	May 7, 2026	-$0.44	-$0.30	+32.15%(+$0.14)
Q4 2025	Feb 19, 2026	-$0.09	-$0.01	+88.86%(+$0.08)
Q3 2025	Nov 6, 2025	-$0.34	-$0.31	+8.92%(+$0.03)
Q2 2025	Aug 6, 2025	-$0.40	-$0.48	-22.41%(-$0.09)

TNDM Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

3.79

3.82

3.86

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Tandem Diabetes Care, Inc.

Tandem Diabetes designs and manufactures insulin pumps and related disposables for diabetes management. Since entering the market in 2012, the company has built a portfolio including its flagship t:slim X2 device and recently launched Mobi pump, with tubeless options (Tobi and Sigi) in development. Pumps account for approximately half of revenue, with disposable infusion sets representing one-third of sales. The company derives roughly 75% of revenue from the US market, with the remainder from other developed nations.

TNDM Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.24

Revenue estimate$265.85M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

ALNTAllient Inc. Common StockInstruments for Measuring
CNMDCONMED CorporationElectromedical Equipment
EYENational Vision Holdings, Inc. Common StockOphthalmic Goods
LYNXLyntris Inc.Defense Systems & Equipment
ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

3.9

Buy

Consensus rating

52-Week Range

Low$12.26

High$29.65